Publications by authors named "Oleg A Yakovlev"

Claim this Profile
D
DARK Classics in Chemical Neuroscience: Arecoline.
Andrey D Volgin, Alim Bashirzade, Tamara G Amstislavskaya, Oleg A Yakovlev, Konstantin A Demin

ACS Chem Neurosci· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zebrafish models for personalized psychiatry: Insights from individual, strain and sex differences, and modeling gene x environment interactions.
Andrey D Volgin, Oleg A Yakovlev, Konstantin A Demin, Murilo S de Abreu, Polina A Alekseeva

J Neurosci Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute behavioral effects of deliriant hallucinogens atropine and scopolamine in adult zebrafish.
Andrey D Volgin, Oleg A Yakovlev, Konstantin A Demin, Polina A Alekseeva, Allan V Kalueff

Behav Brain Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models.
Andrey D Volgin, Oleg A Yakovlev, Konstantin A Demin, Polina A Alekseeva, Evan J Kyzar

ACS Chem Neurosci· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding zebrafish aggressive behavior.
Konstantin N Zabegalov, Tatiana O Kolesnikova, Sergey L Khatsko, Andrey D Volgin, Oleg A Yakovlev

Behav Processes· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zebrafish models relevant to studying central opioid and endocannabinoid systems.
Konstantin A Demin, Darya A Meshalkina, Elana V Kysil, Kristina A Antonova, Andrey D Volgin, Oleg A Yakovlev

Prog Neuropsychopharmacol Biol Psychiatry· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding antidepressant discontinuation syndrome (ADS) through preclinical experimental models.
Konstantin N Zabegalov, Tatiana O Kolesnikova, Sergey L Khatsko, Andrey D Volgin, Oleg A Yakovlev

Eur J Pharmacol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis